Peptide-Based Vaccination for Antibody Responses Against HIV

HIV-1 is responsible for a global pandemic of 35 million people and continues to spread at a rate of >2 million new infections/year. It is widely acknowledged that a protective vaccine would be the most effective means to reduce HIV-1 spread and ultimately eliminate the pandemic, whereas a therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Combadière, Behazine, Beaujean, Manon, Chaudesaigues, Chloé, Vieillard, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789779/
https://www.ncbi.nlm.nih.gov/pubmed/31480779
http://dx.doi.org/10.3390/vaccines7030105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789779/
https://www.ncbi.nlm.nih.gov/pubmed/31480779
http://dx.doi.org/10.3390/vaccines7030105

Ejemplares similares